Novel Expanding Renal Cell Carcinoma Biomarkers
Identification of reliable molecular biomarkers that can complement clinical practice represents a fascinating challenge in any cancer field. Renal tumors are usually asymptomatic and incidentally identified during imaging studies undertaken for unrelated causes. However, in 25% to 30%...
Saved in:
| Main Author: | Francesco Claps, Maria Carmen Mir |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-01-01
|
| Series: | Société Internationale d’Urologie Journal |
| Subjects: | |
| Online Access: | https://siuj.org/index.php/siuj/article/view/60/20 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Promising Biomarkers in Renal Cell Carcinoma
by: Jada Kapoor, Francesco Claps, Carmen Mir, Joseph Ischia
Published: (2021-01-01) -
Prognostic Implications of Serum Carbonic Anhydrase IX in Clear Cell Renal Cell Carcinoma
by: Mónica Sanz del Pozo, et al.
Published: (2025-03-01) -
A novel preoperative inflammatory marker prognostic score in patients with localized and metastatic renal cell carcinoma
by: Rishi R. Sekar, et al.
Published: (2017-10-01) -
The LMR-SSIGN-MAPS model predicts disease-free survival
in patients with localized clear cell renal cell carcinoma
by: Hongzhuang Wen, et al.
Published: (2022-12-01) -
PRSS53 is a potential novel biomarker related to prognosis and immunity in clear cell renal cell carcinoma
by: Jiajun Zhang, et al.
Published: (2025-03-01)